Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Biocartis Idylla™ IDH1-2 Mutation Assay Kit

Products are for professional/laboratory use only

The Idylla IDH1-2 Mutation Assay Kit (RUO)1 can detect five mutations in the IDH1 gene and 10 mutations in the IDH2 gene, along with an integrated processing control. The turnaround time is approximately 95 minutes from sample to result. The assay performance has been evaluated at multiple sites in both the US and Europe.

  • Five mutations in IDH1 and 10 in IDH2 genes.
  • 95 minutes assay turnaround time.
  • Less than five minutes hands-on time.
  • Suitable for both FFPE or extracted DNA samples.
  • Highly sensitive and standardised.
  • Suitable for any lab.

SPECIMEN REQUIREMENTS

Extracted DNA

  • 50 μl extracted DNA
  • Concentration ≥ 10 ng/μl
  • DNA should be extracted from samples with ≥ 10% neoplastic cells

Also compatible with FFPE sections without DNA extraction

  • ≥ 10% neoplastic cells

 

Idylla IDH1-2 Mutation Assay Kit Brochure

Download Brochure >

Technical Sheet Idylla IDH1-2 Mutation Assay Kit

Download Technical Sheet >

References

¹ Idylla IDH1-2 Mutation Assay Kit is for Research Use Only (RUO), not for use in diagnostic procedures.



Request a Quote

Request Quote

Recent Posts

ZytoVision by Zytomics: Fully automated probes for the BOND™ Systems

Product Portfolio: Prod. No. Product Label Tests (Volume) Z-2315-5-1ML ZytoMation ALK Dual Color Break Apart FISH Probe ●/● up to 20 (5.1 ml) Z-2306-5-1ML ZytoMation…

Read full article

Invivoscribe – LymphoTrack Flex

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.Identifying clonality and determining the frequency of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements…

Read full article

Invivoscribe – NPM1 MRD Assay now available globally

Invivoscribe’s NPM1 MRD Assay is an NGS-based, targeted, deep-sequencing assay that detects and monitors DNA sequences specific to identified mutations from the primary sample identified at diagnosis with an allelic sensitivity…

Read full article